Sg Americas Securities, LLC Reata Pharmaceuticals Inc Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	SELL	$79.22 - $105.37 $300,798 - $400,089	-3,797 Reduced 44.37%	4,761 $485,000
Q1 2023 Apr 28, 2023	BUY	$30.85 - $93.17 $49,545 - $149,631	1,606 Added 23.1%	8,558 $778,000
Q4 2022 Feb 02, 2023	SELL	$22.15 - $42.11 $24,697 - $46,952	-1,115 Reduced 13.82%	6,952 $264,000
Q3 2022 Oct 31, 2022	SELL	$19.41 - $36.49 $17,643 - $33,169	-909 Reduced 10.13%	8,067 $203,000
Q2 2022 Jul 29, 2022	BUY	$20.71 - $36.5 $185,892 - $327,624	8,976 New	8,976 $273,000
Q1 2022 Apr 29, 2022	SELL	$24.12 - $39.6 $120,141 - $197,247	-4,981 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$25.61 - $110.96 $219,733 - $952,036	-8,580 Reduced 63.27%	4,981 $131,000
Q3 2021 Nov 01, 2021	BUY	$100.0 - $143.02 $1 Million - $1.43 Million	10,015 Added 282.43%	13,561 $1.36 Million
Q2 2021 Aug 12, 2021	BUY	$78.27 - $151.29 $126,406 - $244,333	1,615 Added 83.64%	3,546 $502,000
Q1 2021 May 13, 2021	SELL	$94.25 - $132.81 $829,871 - $1.17 Million	-8,805 Reduced 82.01%	1,931 $193,000
Q4 2020 Feb 04, 2021	BUY	$102.03 - $184.62 $210,283 - $380,501	2,061 Added 23.76%	10,736 $1.33 Million
Q3 2020 Nov 09, 2020	BUY	$93.53 - $163.34 $464,937 - $811,963	4,971 Added 134.21%	8,675 $845,000
Q2 2020 Jul 20, 2020	SELL	$126.3 - $176.56 $258,409 - $361,241	-2,046 Reduced 35.58%	3,704 $578,000
Q1 2020 Apr 30, 2020	BUY	$124.16 - $247.74 $376,701 - $751,643	3,034 Added 111.71%	5,750 $830,000
Q4 2019 Jan 28, 2020	BUY	$74.57 - $217.92 $202,532 - $591,870	2,716 New	2,716 $555,000
Q3 2019 Nov 04, 2019	SELL	$71.26 - $95.75 $181,926 - $244,449	-2,553 Closed	0 $0
Q2 2019 Jul 29, 2019	SELL	$77.72 - $94.35 $29,766 - $36,136	-383 Reduced 13.04%	2,553 $241,000
Q1 2019 Apr 29, 2019	SELL	$51.9 - $101.79 $6,279 - $12,316	-121 Reduced 3.96%	2,936 $251,000
Q4 2018 Feb 01, 2019	BUY	$48.76 - $76.44 $149,059 - $233,677	3,057 New	3,057 $171,000

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account